[go: up one dir, main page]

ITMI931673A0 - Uso della benzidamina nel trattamento di stati patologici causati dal tnf - Google Patents

Uso della benzidamina nel trattamento di stati patologici causati dal tnf

Info

Publication number
ITMI931673A0
ITMI931673A0 IT93MI1673A ITMI931673A ITMI931673A0 IT MI931673 A0 ITMI931673 A0 IT MI931673A0 IT 93MI1673 A IT93MI1673 A IT 93MI1673A IT MI931673 A ITMI931673 A IT MI931673A IT MI931673 A0 ITMI931673 A0 IT MI931673A0
Authority
IT
Italy
Prior art keywords
benzidamine
tnf
treatment
pathological states
states caused
Prior art date
Application number
IT93MI1673A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of ITMI931673A0 publication Critical patent/ITMI931673A0/it
Priority to IT93MI001673A priority Critical patent/IT1276040B1/it
Priority to AU73861/94A priority patent/AU692458B2/en
Priority to US08/586,804 priority patent/US6300358B1/en
Priority to SK105-96A priority patent/SK281895B6/sk
Priority to PT94923739T priority patent/PT711163E/pt
Priority to ES94923739T priority patent/ES2163450T3/es
Priority to HU9600182A priority patent/HU226805B1/hu
Priority to JP50552795A priority patent/JP3587851B2/ja
Priority to AT94923739T priority patent/ATE207353T1/de
Priority to PCT/EP1994/002343 priority patent/WO1995003799A1/en
Priority to RU96105062/14A priority patent/RU2160102C2/ru
Priority to CZ96255A priority patent/CZ285864B6/cs
Priority to NZ269563A priority patent/NZ269563A/en
Priority to SI9430373T priority patent/SI0711163T1/xx
Priority to DE69428797T priority patent/DE69428797T2/de
Priority to PL94312741A priority patent/PL312741A1/xx
Priority to RO96-00144A priority patent/RO117149B1/ro
Priority to DK94923739T priority patent/DK0711163T3/da
Priority to EP94923739A priority patent/EP0711163B1/en
Priority to CA002167926A priority patent/CA2167926C/en
Priority to ZA945431A priority patent/ZA945431B/xx
Publication of ITMI931673A1 publication Critical patent/ITMI931673A1/it
Priority to NO960347A priority patent/NO308195B1/no
Priority to LVP-96-46A priority patent/LV11524B/en
Priority to BG100385A priority patent/BG62841B1/bg
Priority to CN94193377A priority patent/CN1085528C/zh
Application granted granted Critical
Publication of IT1276040B1 publication Critical patent/IT1276040B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT93MI001673A 1993-07-27 1993-07-27 Uso della benzidamina nel trattamento di stati patologici causati dal tnf IT1276040B1 (it)

Priority Applications (25)

Application Number Priority Date Filing Date Title
IT93MI001673A IT1276040B1 (it) 1993-07-27 1993-07-27 Uso della benzidamina nel trattamento di stati patologici causati dal tnf
NZ269563A NZ269563A (en) 1993-07-27 1994-07-14 Use of benzydamine in the treatment of pathological conditions caused by TNF
DE69428797T DE69428797T2 (de) 1993-07-27 1994-07-14 Verwendung von benzydamin zur behandlung von krankheitszuständen, die durch tnf verursacht werden
SK105-96A SK281895B6 (sk) 1993-07-27 1994-07-14 Použitie benzydamínu na prípravu liečiva na liečenie patologických stavov spôsobených tumor necrosis factorom
PT94923739T PT711163E (pt) 1993-07-27 1994-07-14 Utilizacao de benzidamina no tratamento de estados patologicos provocados por tnf
ES94923739T ES2163450T3 (es) 1993-07-27 1994-07-14 Utilizacion de benzidamina en el tratamiento de estados patologicos causados por tnf.
HU9600182A HU226805B1 (en) 1993-07-27 1994-07-14 Use of benzydamine for producing pharmaceutical compositions for treatment of pathological conditions caused by tnf
JP50552795A JP3587851B2 (ja) 1993-07-27 1994-07-14 Ｔｎｆ誘発病状の治療におけるベンジダミンの使用
AT94923739T ATE207353T1 (de) 1993-07-27 1994-07-14 Verwendung von benzydamin zur behandlung von krankheitszuständen, die durch tnf verursacht werden
PCT/EP1994/002343 WO1995003799A1 (en) 1993-07-27 1994-07-14 Use of benzydamine in the treatment of pathological conditions caused by tnf
RU96105062/14A RU2160102C2 (ru) 1993-07-27 1994-07-14 Применение бензидамина для лечения патологических состояний, вызванных фно
CZ96255A CZ285864B6 (cs) 1993-07-27 1994-07-14 Použití benzydaminu pro léčení patologických stavů způsobených TNF
AU73861/94A AU692458B2 (en) 1993-07-27 1994-07-14 Use of benzydamine in the treatment of pathological conditions caused by TNF
SI9430373T SI0711163T1 (en) 1993-07-27 1994-07-14 Use of benzydamine in the treatment of pathological conditions caused by tnf
US08/586,804 US6300358B1 (en) 1993-07-27 1994-07-14 Use of benzydamine in the treatment of pathological conditions caused by TNF
PL94312741A PL312741A1 (en) 1993-07-27 1994-07-14 Application of benidamine in treatment of pathologies caused by tnf
RO96-00144A RO117149B1 (ro) 1993-07-27 1994-07-14 Metoda de tratament a unei stari patologice cauzate de factorul de necroza tumorala
DK94923739T DK0711163T3 (da) 1993-07-27 1994-07-14 Anvendelse af benzydamin i behandlingen af patologiske tilstande forårsaget af TNF
EP94923739A EP0711163B1 (en) 1993-07-27 1994-07-14 Use of benzydamine in the treatment of pathological conditions caused by tnf
CA002167926A CA2167926C (en) 1993-07-27 1994-07-14 Use of benzydamine in the treatment of pathological conditions caused by tnf
ZA945431A ZA945431B (en) 1993-07-27 1994-07-22 Use of benzydamine in the treatment of pathological conditions caused by TNF
NO960347A NO308195B1 (no) 1993-07-27 1996-01-26 Anvendelse av benzydamin til fremstilling av et legemiddel ved behandling av patologiske tilstander forÕrsaket av TNF
LVP-96-46A LV11524B (en) 1993-07-27 1996-02-15 Use of benzydamine in the treatment of pathological conditions caused by tnf
BG100385A BG62841B1 (bg) 1993-07-27 1996-02-26 Използване на бензидамин за лечение на патологичнисъстояния, причинени от туморнекрозен фактор
CN94193377A CN1085528C (zh) 1993-07-27 1996-07-14 炎痛静在治疗由tnf引起的病理疾病中的用途

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT93MI001673A IT1276040B1 (it) 1993-07-27 1993-07-27 Uso della benzidamina nel trattamento di stati patologici causati dal tnf

Publications (3)

Publication Number Publication Date
ITMI931673A0 true ITMI931673A0 (it) 1993-07-27
ITMI931673A1 ITMI931673A1 (it) 1995-01-27
IT1276040B1 IT1276040B1 (it) 1997-10-24

Family

ID=11366694

Family Applications (1)

Application Number Title Priority Date Filing Date
IT93MI001673A IT1276040B1 (it) 1993-07-27 1993-07-27 Uso della benzidamina nel trattamento di stati patologici causati dal tnf

Country Status (25)

Country Link
US (1) US6300358B1 (it)
EP (1) EP0711163B1 (it)
JP (1) JP3587851B2 (it)
CN (1) CN1085528C (it)
AT (1) ATE207353T1 (it)
AU (1) AU692458B2 (it)
BG (1) BG62841B1 (it)
CA (1) CA2167926C (it)
CZ (1) CZ285864B6 (it)
DE (1) DE69428797T2 (it)
DK (1) DK0711163T3 (it)
ES (1) ES2163450T3 (it)
HU (1) HU226805B1 (it)
IT (1) IT1276040B1 (it)
LV (1) LV11524B (it)
NO (1) NO308195B1 (it)
NZ (1) NZ269563A (it)
PL (1) PL312741A1 (it)
PT (1) PT711163E (it)
RO (1) RO117149B1 (it)
RU (1) RU2160102C2 (it)
SI (1) SI0711163T1 (it)
SK (1) SK281895B6 (it)
WO (1) WO1995003799A1 (it)
ZA (1) ZA945431B (it)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2201736C1 (ru) * 2001-12-24 2003-04-10 Закрытое акционерное общество "Брынцалов-А" Ушные капли бротинум
CN101199515B (zh) * 2007-12-21 2010-12-08 重庆市莱美药物技术有限公司 盐酸苄达明洗剂及其制备方法
UA103791C2 (uk) * 2009-02-10 2013-11-25 Селджин Корпорейшн Композиція, що включає модулятор pde4, і спосіб її застосування для лікування, профілактики або супроводу туберкульозу
AU2010270425B2 (en) * 2009-07-08 2016-07-28 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Use of benzydamine in the treatment of p40-dependent diseases
MD4291C1 (ro) * 2013-12-27 2015-02-28 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Preparat medicamentos pentru tratamentul otitelor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054833A (it) * 1963-08-09
US4980160A (en) * 1986-10-16 1990-12-25 Biogen, Inc. Combinations of tumor necrosis factors and anti-inflammatory agents and methods for treating malignant and non-malignant diseases
GB8807803D0 (en) * 1988-03-31 1988-05-05 Glaxo Group Ltd Biochemical product
IL95031A (en) * 1989-07-18 2007-03-08 Amgen Inc Method for the production of a human recombinant tumor necrosis factor inhibitor
US5563143A (en) * 1994-09-21 1996-10-08 Pfizer Inc. Catechol diether compounds as inhibitors of TNF release

Also Published As

Publication number Publication date
CZ25596A3 (en) 1996-07-17
RO117149B1 (ro) 2001-11-30
CN1130872A (zh) 1996-09-11
US6300358B1 (en) 2001-10-09
RU2160102C2 (ru) 2000-12-10
CA2167926C (en) 2004-12-21
IT1276040B1 (it) 1997-10-24
HUT73500A (en) 1996-08-28
PT711163E (pt) 2002-04-29
ITMI931673A1 (it) 1995-01-27
WO1995003799A1 (en) 1995-02-09
DE69428797T2 (de) 2002-04-18
EP0711163B1 (en) 2001-10-24
CN1085528C (zh) 2002-05-29
EP0711163A1 (en) 1996-05-15
DK0711163T3 (da) 2001-11-26
SK281895B6 (sk) 2001-09-11
CA2167926A1 (en) 1995-02-09
LV11524B (en) 1996-12-20
BG100385A (bg) 1996-09-30
ES2163450T3 (es) 2002-02-01
NO308195B1 (no) 2000-08-14
SI0711163T1 (en) 2001-12-31
ZA945431B (en) 1995-02-28
SK10596A3 (en) 1997-03-05
NZ269563A (en) 2001-03-30
BG62841B1 (bg) 2000-09-29
JP3587851B2 (ja) 2004-11-10
DE69428797D1 (de) 2001-11-29
LV11524A (lv) 1996-10-20
NO960347D0 (no) 1996-01-26
NO960347L (no) 1996-03-07
JPH09500385A (ja) 1997-01-14
HU226805B1 (en) 2009-10-28
ATE207353T1 (de) 2001-11-15
AU692458B2 (en) 1998-06-11
CZ285864B6 (cs) 1999-11-17
AU7386194A (en) 1995-02-28
PL312741A1 (en) 1996-05-13

Similar Documents

Publication Publication Date Title
BR9102988A (pt) Kit de estences e painel de desenho
KR900014297U (ko) 휴대용 정수기
KR940022000U (ko) 지압 측정기
ITMI932412A1 (it) Uso di alfa 1-bloccanti nel trattamento della eiaculazione precoce
ITMI912509A0 (it) Uso della nimesulide nel trattamento della cataratta
ITMI931673A0 (it) Uso della benzidamina nel trattamento di stati patologici causati dal tnf
IT8920984A0 (it) Composizione per il trattamento della nevralgia erpetica acuta e la nevralgia post erpetica.
KR910008699U (ko) 보조 정수기
KR900017058U (ko) 휴대용 정수기
KR960013412U (ko) 자석을 내장한 지압구
KR900012337U (ko) 판넬 받침 장치
KR900018405U (ko) 휴대용 정수기
ITMI931800A0 (it) Uso della 4 -desossi-4-iododoxorubicina per il trattamento della alamiloidosi
KR960030486U (ko) 지압측정기가 부착된 지압구
ITRM940063A1 (it) Simulatore meccanico del movimento della mandibola in rapporto alla mascella.
KR950010864U (ko) 자석이 매입된 에프알피(frp)욕조
KR950010901U (ko) 지압 측정기
BR6900693U (pt) Disposicao construtiva em sauna
BR8904976A (pt) Painel pre-fabricado
KR910002634U (ko) 정수기
KR910008644U (ko) 지압기
KR950010923U (ko) 자기 지압을 갖는 지압구
KR940021107U (ko) 보통 전력량계 지침 투시 확대경
BR7302160U (pt) Sauna residencial
KR970010252U (ko) 이중구조 형상을 갖는 오링

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970724